Dayananda Kasala

477 total citations
17 papers, 410 citations indexed

About

Dayananda Kasala is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Dayananda Kasala has authored 17 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 13 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Dayananda Kasala's work include Virus-based gene therapy research (15 papers), RNA Interference and Gene Delivery (13 papers) and CAR-T cell therapy research (6 papers). Dayananda Kasala is often cited by papers focused on Virus-based gene therapy research (15 papers), RNA Interference and Gene Delivery (13 papers) and CAR-T cell therapy research (6 papers). Dayananda Kasala collaborates with scholars based in South Korea, United States and Taiwan. Dayananda Kasala's co-authors include Chae‐Ok Yun, Sung Wan Kim, Joung-Woo Choi, JinWoo Hong, A‐Rum Yoon, Youjin Na, Soo‐Hwan Lee, Joung-Woo Choi, Sung Wan Kim and You Han Bae and has published in prestigious journals such as Biomaterials, Chemical Engineering Journal and Journal of Controlled Release.

In The Last Decade

Dayananda Kasala

17 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dayananda Kasala South Korea 11 269 265 155 90 47 17 410
Joung-Woo Choi South Korea 10 251 0.9× 247 0.9× 138 0.9× 76 0.8× 42 0.9× 11 367
Pyung-Hwan Kim South Korea 12 474 1.8× 370 1.4× 195 1.3× 87 1.0× 56 1.2× 13 635
Joung-Woo Choi South Korea 8 254 0.9× 235 0.9× 132 0.9× 62 0.7× 69 1.5× 8 392
Erlinda Quijano Germany 7 296 1.1× 200 0.8× 90 0.6× 80 0.9× 45 1.0× 7 466
Yusuke Eto Japan 13 390 1.4× 359 1.4× 119 0.8× 82 0.9× 23 0.5× 20 508
Baowei Peng China 13 219 0.8× 90 0.3× 136 0.9× 74 0.8× 52 1.1× 26 556
Simon S. Briggs United Kingdom 12 660 2.5× 369 1.4× 99 0.6× 31 0.3× 54 1.1× 15 775
Jere T. Pikkarainen Finland 12 368 1.4× 174 0.7× 107 0.7× 43 0.5× 107 2.3× 16 594
Jennifer L. Leddon United States 9 404 1.5× 167 0.6× 251 1.6× 23 0.3× 114 2.4× 15 700
Orestis Argyros United Kingdom 15 406 1.5× 215 0.8× 57 0.4× 14 0.2× 30 0.6× 21 536

Countries citing papers authored by Dayananda Kasala

Since Specialization
Citations

This map shows the geographic impact of Dayananda Kasala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dayananda Kasala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dayananda Kasala more than expected).

Fields of papers citing papers by Dayananda Kasala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dayananda Kasala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dayananda Kasala. The network helps show where Dayananda Kasala may publish in the future.

Co-authorship network of co-authors of Dayananda Kasala

This figure shows the co-authorship network connecting the top 25 collaborators of Dayananda Kasala. A scholar is included among the top collaborators of Dayananda Kasala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dayananda Kasala. Dayananda Kasala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kim, Young‐Beom, Soo‐Hwan Lee, Dayananda Kasala, et al.. (2025). Potent therapeutic efficacy of intranasally deliverable paclitaxel modified with pH-sensitive and PEGylated polymeric micelle against glioblastoma. Journal of Controlled Release. 382. 113711–113711. 2 indexed citations
2.
Kasala, Dayananda, Ao Jiao, Soo‐Hwan Lee, et al.. (2025). Potent antitumor effect of intranasally administrable pH-sensitive and photothermal polymeric oncolytic adenovirus for the treatment of brain cancer. Chemical Engineering Journal. 505. 159770–159770. 3 indexed citations
3.
Yoon, A‐Rum, et al.. (2024). Synergistic antitumor immune response mediated by paclitaxel-conjugated nanohybrid oncolytic adenovirus with dendritic cell therapy. Frontiers in Immunology. 15. 1355566–1355566. 2 indexed citations
4.
Thambi, Thavasyappan, Jeongmin Lee, A‐Rum Yoon, Dayananda Kasala, & Chae‐Ok Yun. (2022). A pH- and Bioreducible Cationic Copolymer with Amino Acids and Piperazines for Adenovirus Delivery. Pharmaceutics. 14(3). 597–597. 5 indexed citations
6.
Kasala, Dayananda, JinWoo Hong, & Chae‐Ok Yun. (2021). Overcoming the barriers to optimization of adenovirus delivery using biomaterials: Current status and future perspective. Journal of Controlled Release. 332. 285–300. 12 indexed citations
7.
Kasala, Dayananda, Soo‐Hwan Lee, Jin Hong, et al.. (2017). Synergistic antitumor effect mediated by a paclitaxel-conjugated polymeric micelle-coated oncolytic adenovirus. Biomaterials. 145. 207–222. 37 indexed citations
8.
Yoon, A‐Rum, Dayananda Kasala, Yan Li, et al.. (2016). Antitumor effect and safety profile of systemically delivered oncolytic adenovirus complexed with EGFR-targeted PAMAM-based dendrimer in orthotopic lung tumor model. Journal of Controlled Release. 231. 2–16. 42 indexed citations
9.
Yoon, A‐Rum, Dayananda Kasala, Yan Li, et al.. (2016). 109. Therapeutic Efficacy and Safety Profile of EGFR-Targeted Oncolytic Ad Nanocomplex in Orthotopic Lung Tumor Model. Molecular Therapy. 24. S46–S46. 1 indexed citations
10.
Kasala, Dayananda, A‐Rum Yoon, JinWoo Hong, Sung Wan Kim, & Chae‐Ok Yun. (2016). Evolving Lessons on Nanomaterial-Coated Viral Vectors for Local and Systemic Gene Therapy. Nanomedicine. 11(13). 1689–1713. 32 indexed citations
11.
Choi, Joung-Woo, et al.. (2015). pH-sensitive oncolytic adenovirus hybrid targeting acidic tumor microenvironment and angiogenesis. Journal of Controlled Release. 205. 134–143. 48 indexed citations
12.
Na, Youjin, Joung-Woo Choi, Dayananda Kasala, et al.. (2015). Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model. Journal of Controlled Release. 220(Pt B). 766–782. 44 indexed citations
13.
Kasala, Dayananda, Youjin Na, Min Sang Lee, et al.. (2014). Enhanced therapeutic efficacy of an adenovirus-PEI-bile-acid complex in tumors with low coxsackie and adenovirus receptor expression. Biomaterials. 35(21). 5505–5516. 49 indexed citations
14.
Kasala, Dayananda, Joung-Woo Choi, Sung Wan Kim, & Chae‐Ok Yun. (2014). Utilizing adenovirus vectors for gene delivery in cancer. Expert Opinion on Drug Delivery. 11(3). 379–392. 34 indexed citations
15.
Moon, Chang, et al.. (2014). Dual tumor targeting with pH-sensitive and bioreducible polymer-complexed oncolytic adenovirus. Biomaterials. 41. 53–68. 36 indexed citations
16.
17.
Kasala, Dayananda, Chiao‐Yun Chen, Gin‐Chung Liu, et al.. (2011). [Gd(Try-TTDA)(H2O)]2−: A new MRI contrast agent for copper ion sensing. Dalton Transactions. 40(18). 5018–5018. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026